94 related articles for article (PubMed ID: 11244716)
1. [Beta-catenin: its discovery as a cadherin-associated protein and its function as a transcription activator].
Ozawa M
Tanpakushitsu Kakusan Koso; 2001 Mar; 46(3):197-207. PubMed ID: 11244716
[No Abstract] [Full Text] [Related]
2. Tyrosine phosphorylation translocates beta-catenin from cell-->cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function.
Kim K; Lee KY
Cell Biol Int; 2001; 25(5):421-7. PubMed ID: 11401329
[TBL] [Abstract][Full Text] [Related]
3. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
4. Beta-catenin is critical for dendritic morphogenesis.
Yu X; Malenka RC
Nat Neurosci; 2003 Nov; 6(11):1169-77. PubMed ID: 14528308
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic transformation by beta-catenin: deletion analysis and characterization of selected target genes.
Aoki M; Sobek V; Maslyar DJ; Hecht A; Vogt PK
Oncogene; 2002 Oct; 21(46):6983-91. PubMed ID: 12370820
[TBL] [Abstract][Full Text] [Related]
6. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
Asally M; Yoneda Y
Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
[TBL] [Abstract][Full Text] [Related]
7. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L
Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853
[TBL] [Abstract][Full Text] [Related]
8. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.
Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW
J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway.
Debiais F; Lefèvre G; Lemonnier J; Le Mée S; Lasmoles F; Mascarelli F; Marie PJ
Exp Cell Res; 2004 Jul; 297(1):235-46. PubMed ID: 15194439
[TBL] [Abstract][Full Text] [Related]
10. [Regulation of transcription in the Wnt signaling pathway].
Yamashina K; Kikuchi A
Tanpakushitsu Kakusan Koso; 2004 Aug; 49(10):1421-7. PubMed ID: 15346893
[No Abstract] [Full Text] [Related]
11. Wnt signalling: a theme with nuclear variations.
Sharpe C; Lawrence N; Martinez Arias A
Bioessays; 2001 Apr; 23(4):311-8. PubMed ID: 11268036
[TBL] [Abstract][Full Text] [Related]
12. A yeast model system for functional analysis of beta-catenin signaling.
Lee MS; D'Amour KA; Papkoff J
J Cell Biol; 2002 Sep; 158(6):1067-78. PubMed ID: 12235124
[TBL] [Abstract][Full Text] [Related]
13. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
[TBL] [Abstract][Full Text] [Related]
14. Direct metabolic regulation of beta-catenin activity by the p85alpha regulatory subunit of phosphoinositide 3-OH kinase.
Espada J; Peinado H; Esteller M; Cano A
Exp Cell Res; 2005 May; 305(2):409-17. PubMed ID: 15817165
[TBL] [Abstract][Full Text] [Related]
15. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
Hagen T; Vidal-Puig A
Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
[TBL] [Abstract][Full Text] [Related]
17. Taxol reduces cytosolic E-cadherin and beta-catenin levels in nasopharyngeal carcinoma cell line TW-039: cross-talk between the microtubule- and actin-based cytoskeletons.
Lou PJ; Chen WP; Lin CT; Chen HC; Wu JC
J Cell Biochem; 2000 Sep; 79(4):542-56. PubMed ID: 10996845
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction: signaling specificity- a complex affair.
Weston CR; Davis RJ
Science; 2001 Jun; 292(5526):2439-40. PubMed ID: 11431552
[No Abstract] [Full Text] [Related]
19. "Decisions, decisions.": beta-catenin-mediated activation of TCF-1 and Lef-1 influences the fate of developing T cells.
Wu L; Strasser A
Nat Immunol; 2001 Sep; 2(9):823-4. PubMed ID: 11526393
[No Abstract] [Full Text] [Related]
20. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation.
Persad S; Troussard AA; McPhee TR; Mulholland DJ; Dedhar S
J Cell Biol; 2001 Jun; 153(6):1161-74. PubMed ID: 11402061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
